Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia
NCT ID: NCT04428463
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
27 participants
INTERVENTIONAL
2020-06-30
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The gold standard for treatment of perforations is tympanic membrane closure procedure (tympanoplasty) which is done under general anesthesia.
This procedure could be problematic for many patients who are not suitable for general anesthesia due to their medical status.
It's also time consuming for the patient and for the medical system, since it takes a lot of time to reach the operation room and hospitalization for at least two days.
The purpose in this study is to use Tachosil (Fibrinogen based patch) under local anesthesia to close tympanic membrane perforations.
Tachosil is in use for hemostasis and for tissue repair after injury. Tachosil is bound to the tissue and form a waterproof membrane. In the setting of ENT clinic and under local anesthesia, the investigators will start the procedure with debridement of the tympanic perforation edges, then they will close the perforation using two pieces of Tachosil under and above the perforation in the right form (active side to the active side).
If the results will be similar to tympanoplasty results, this method may be used for closure of tympanic perforation and save time and money for the patient and for the health system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Tympanoplasty With Membrane Amniotic and Autologous Fascia
NCT03569969
In-office Repair of Chronic Tympanic Membrane Perforations
NCT06448039
Role of Hyaluronic Acid Gel as an Adjunct to Temporalis Facia Graft in Tympanoplasty for Total Tympanic Membrane Perforation
NCT07233226
Tympanoseal Clinical Study
NCT05849844
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT04960384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is done under general anesthesia in the following form:
Incision in the post auricular area, harvesting of fascia and cartilage from the concha of the pinna .
In Trans ear canal approach starting with debridement of the edges of the tympanic membrane perforation and closing the perforation using cartilage and fascia.
After being informed about the study and potential risks, all patients giving informed consent will participate in the study.
This study will include two groups. The first group will be treated with the conventional way as described above. The interventional group will be treated using Tachosil in the following order:
Local anesthesia using Lidocadren (lidocaine and epinephrine) will be injected to the ear canal using dental needle.
Debridement of the edges of the tympanic membrane perforation Placing the tachosil under and above the perforation in the correct order. The patient could be discharged home immediately after the procedure if no adverse effects are seen (dizziness, nausea or vomiting).
After one month, similar to the conventional treatment method, the patient will be invited to the otology clinic, for hearing test and microscopic examuntaion of the tympanic membrane, to see if the perforation is closed.
The study will compare the success rate in the two groups and if it will be similar that will help publish this method and use it in patients who are not suitable to general anesthesia and in hospitals were waiting time table for operation room is very long.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
in the intervention group we will use tachosil in closing the perforations.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tympanoplasty using fascia and cartilage
tympanoplasty under general anesthesia using fascia and cartilage witch is the gold standard for treating tympanic membrane perforations.
fascia and cartilage
tympanic membrane perforation repair using fascia and cartilage under general anesthesia
Tachosil
repair of tympanic perforations under local anesthesia using Tachosil patch.
Tachosil
tympanic membrane perforation repair using Tachosil patch under local anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tachosil
tympanic membrane perforation repair using Tachosil patch under local anesthesia
fascia and cartilage
tympanic membrane perforation repair using fascia and cartilage under general anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* dry ear at least 4 weeks before the procedure
* no evidence of cholesteatoma
* hearing test in the last 3 months
* signing informed consent
Exclusion Criteria
* pregnant
* breastfeeding
* a known sensitivity for any ingredient
* a perforation that is more than one third of the tympanic membrane area.
* new onset perforation (less than 3 months)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMC-13-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.